Director/PDMR Shareholding

 

TIDMGWP 
 
RNS Number : 4255S 
GW Pharmaceuticals PLC 
09 September 2010 
 
 
         GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company") 
 
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 
Porton Down, UK, 8 September 2010: GW Pharmaceuticals (AIM: GWP) hereby provides 
notification that the Company has today been notified of the following series of 
share transactions entered into by Dr Geoffrey Guy, a Director and Executive 
Chairman of the Company. 
 
On 3rd September Dr Guy transferred 8,660 ordinary shares of 0.1p each, equating 
to 0.01% of the issued ordinary share capital of the company, into his personal 
pension scheme. Dr Guy also sold 1,326 ordinary shares of 0.1p each, equating to 
less than 0.01% of the issued ordinary share capital of the company, at the 
market price of 103 pence per share. On 6th September Dr Guy sold 25,000 
ordinary shares of 0.1p each, equating to 0.02% of the issued ordinary share 
capital of the Company, at the market price of 101 pence per share. Dr Guy has 
today transferred a further 4,850 ordinary shares of 0.1p each, equating to less 
than 0.01% of the issued ordinary share capital, into his personal pension 
scheme. 
 
Following this notification Dr Guy retains a beneficial interest in 18,325,115 
ordinary shares, amounting to 14.07% of the shares in issue. The total number of 
shares outstanding in the Company is 130,210,209 ordinary shares of 0.1p each. 
 
 
For further information, please contact: 
 
GW Pharmaceuticals PLC                                                +44 
(0)1980 557 000 
Adam George, Company Secretary 
 
Piper Jaffray Ltd (Nominated Adviser) 
Neil Mackison/Rupert Winckler                                          +44  (0) 
203 142 8700 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 RDSLLFSIAAIAIII